This study aims to identify and address solvable barriers to CAR T-cell therapy for patients with relapsed and refractory multiple myeloma, improving access, support, and patient care.

For any questions or concerns regarding the study, participants can contact HealthTree Patient Navigators at support@healthtree.org.